Drug intelligence / Profile preview

gelatin

Development stage
Phase 4
Lead developer
B. Braun
Modality
Recombinant Proteins and Enzymes, Peptides
Administration
Oral, Intravenous, Topical, Surgical Implantation
01

Overview

Gelatin is a proteinaceous substance produced by the partial hydrolysis of collagen derived from animal connective tissues, bones, and skin. In clinical medicine, it is primarily utilized as a synthetic colloid solution for intravenous plasma volume expansion. Its therapeutic application is centered on the management of hypovolemia, shock (including septic and post-traumatic shock), and the stabilization of hemodynamics in critically ill patients. Gelatin works by increasing the plasma oncotic pressure, which facilitates the retention and recruitment of fluid within the intravascular compartment. Beyond its use as a volume expander, gelatin is also employed as a dietary supplement; research indicates that oral ingestion of gelatin protein can stimulate the release of growth hormone (GH) from the anterior pituitary, potentially aiding in the management of metabolic syndrome and obesity. However, clinical studies in intensive care settings have associated the use of gelatin-based resuscitation fluids with an increased risk of acute kidney injury (AKI) compared to crystalloid solutions.

Brand names
GelofusineHaemaccel
Other names
gelatinemodified fluid gelatinsuccinylated gelatinpartially hydrolyzed gelatingelatin protein

Beyond the preview

Go deeper on gelatin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on gelatin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call